FCGR3A and Hodgkins lymphoma: For example, AFM13, a bispecific antibody targeting CD30 [a prominent marker of relapsed/refractory (R/R) Hodgkin lymphoma] and CD16A, mediates in vivo ADCC and NK cell retention activity (35, 36).